{"nct_id":"NCT07017725","title":"A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2025-01-03","start_date_type":"ACTUAL","primary_completion_date":"2026-06-01","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["CASI"]}